Sarcopenia is common in ulcerative colitis and correlates with disease activity
- Author:
Pardhu B NEELAM
1
;
Rimesh PAL
;
Pankaj GUPTA
;
Anupam K SINGH
;
Jimil SHAH
;
Harshal S MANDAVDHARE
;
Harjeet SINGH
;
Aravind SEKAR
;
Sanjay K BHADADA
;
Usha DUTTA
;
Vishal SHARMA
Author Information
- Publication Type:Original Article
- From:Intestinal Research 2024;22(2):162-171
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background/Aims:Association of sarcopenia with disease severity in ulcerative colitis (UC) is not clearly defined. We planned to estimate the prevalence of sarcopenia in patients with UC as per the revised definition and its relation with the disease severity.
Methods:A cross-sectional assessment of sarcopenia in patients with UC was performed. Disease activity was graded according to complete Mayo score. Hand grip strength was assessed with Jamar hand dynamometer, muscle mass using a dual energy X-ray absorptiometry scan, and physical performance with 4-m walk test. Sarcopenia was defined as a reduction of both muscle mass and strength. Severe sarcopenia was defined as reduced gait speed in presence of sarcopenia.
Results:Of 114 patients (62 males, mean age: 36.49±12.41 years), 32 (28%) were in remission, 46 (40.4%) had mild-moderate activity, and 36 (31.6%) had severe UC. Forty-three patients (37.7%) had probable sarcopenia, 25 (21.9%) had sarcopenia, and 14 (12.2%) had severe sarcopenia. Prevalence of sarcopenia was higher in active disease (2 in remission, 6 in active, and 17 in severe, P<0.001). Of 14 with severe sarcopenia, 13 had severe UC while 1 had moderate UC. On multivariate analysis, lower body mass index and higher Mayo score were associated with sarcopenia. Of 37 patients with acute severe colitis, 16 had sarcopenia. Requirement of second-line therapy was similar between patients with and without sarcopenia. On follow-up (median: 18 months), there was a non-significant higher rate of major adverse events in those with sarcopenia (47.4% vs. 33.8%, P=0.273).
Conclusions:Sarcopenia and severe sarcopenia in UC correlate with the disease activity.
